BioWorld Asia

April 18, 2007

Australia Gearing Up For Votes To Allow Therapeutic Cloning

MELBOURNE, AUSTRALIA - Australia is set to join countries that allow therapeutic cloning, with a vote on the issue due later this week in the Victoria State Parliament. (BioWorld International) Read More

Transgene Partners with Roche In HPV Vaccine Development

'Mysterious' Obesity Gene Helps To Pile On The Pounds

Bavarian Lands $545M Deal For Smallpox Vaccine Stockpile

TopoTarget Acquiring Apoxis In Stock Deal Worth $20M

DeveloGen Selling Phase III Diabetes Program To Andromeda

Other News To Note

Report Says Europe Recovering Nicely From Post-Genome Bust . . .

. . . But EU Says Much Is Still Desired From Unity Standpoint

Today's news in brief

BioWorld

BioWorld briefs for March 10, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 10, 2026

MSD synthesizes α-synuclein PET agents

BioWorld Science

Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...